World of DTC Marketing

MAY 3, 2022

Yet the company moved ahead because the CEO was under pressure to justify the money the company had invested in the drug. In trying to save the product, Biogen’s reputation was trashed by FDA advisors, HCPs, and the healthcare media. 4our: The FDA advisors and Aduhelm. 5ive: The CEO became combative.

Pharma Companies 207

Pharma Companies Drugs FDA Approval Production 207

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

AUGUST 21, 2023

The US Food and Drug Administration (FDA) has approved Ipsen’s groundbreaking Sohonos (palovarotene) capsules for the treatment of fibrodysplasia ossificans progressive (FOP), an ultra-rare bone disease. Sohonos, the first and only approved drug, offers hope to those battling the disease.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year.

FDA Approval 147

FDA Approval Marketing Manufacturing Sales 147

XTalks

NOVEMBER 2, 2023

Amgen’s Wezlana (ustekinumab-auub) has received US Food and Drug Administration (FDA) approval as a Stelara biosimilar for the treatment of several inflammatory diseases including Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and psoriatic arthritis.

FDA Approval 59

FDA Approval Production Dermatology Sales 59

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 97

Drugs Antibody Pharma Companies Development 97

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3

Production 213

Production Drugs Development Marketing 213

XTalks

AUGUST 18, 2020

SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). Last month, the FDA approved a pooled test for COVID-19 developed by Quest Diagnostics. It’s sensitive.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Delveinsight

FEBRUARY 9, 2021

Breyanzi, BMS’ Blood Cancer CAR-T Therapy Receives FDA Nod. Breyanzi will come with a price tag of USD 410,300 wholesale price, said the company, justifying it after taking into consideration several factors including medical and clinical value, patient value, and societal value. The drug received priority review for the MZL.

FDA Approval 52

FDA Approval Marketing Research Protein 52

Drug Discovery World

MAY 1, 2024

Many of the best-selling drugs in 2023 were monoclonal antibody (mAB) therapies, including Keytruda (pembrolizumab), Humira (adalimumab), and Dupixent (dupilumab) 1. Ben Holland, Co-Founder and CTO of Antiverse, notes that AI and machine learning now touch 10% of drug discovery projects.

Antibody 59

Antibody FDA Approval Drugs Development 59

World of DTC Marketing

JANUARY 1, 2022

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.

Marketing 244

Marketing Doctors Doctor FDA Approval 244

Pharmaceutical Technology

SEPTEMBER 2, 2022

This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie. lenalidomide) + a steroid ± an anti-CD38 antibody.

Antibody 147

Antibody Sales FDA Approval Production 147

Pharmaceutical Technology

JUNE 30, 2022

Nonprofits like the Drugs for Neglected Diseases initiative (DNDi) and independent researchers are studying diseases such as river blindness, which are missing more targeted and effective treatments. Treatments for tropical diseases such as schistosomiasis or trachoma feature the use of mass drug administrations.

Pharma Companies 162

Pharma Companies FDA Approval Development Drugs 162

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

pharmaphorum

AUGUST 4, 2022

Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 billion bid to buy out the company. The drug is already approved in Japan for ANC vasculitis, but is sold there by Kissei Pharma, while Otsuka has commercial rights to it in Canada.

Sales 95

Sales FDA Approval Pharma Companies Drugs 95

XTalks

DECEMBER 20, 2023

These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. The shortages have been partly blamed on the off-label prescribing of the drugs for weight loss.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

DECEMBER 21, 2021

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. Headway being made.

Development 98

Development Genome Genomics Drugs 98

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

DECEMBER 14, 2021

Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etrasimod. The $100-per-share deal values Arena at around $6.7

FDA Approval 98

FDA Approval Pharma Companies Production Drugs 98

Drug Discovery World

APRIL 27, 2023

Dr Mansley also comments that the multitude of biotech and pharma companies in the Greater Boston region means that people regularly move organisations. She said: “When one of our customers leaves a company and moves to a new one up the street, they often get in touch with us, which helps us grow new business.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Engineer 100

pharmaphorum

FEBRUARY 15, 2022

ImmunoGenAlmost four years after backing out of an antibody-drug conjugate (ADC) alliance with ImmunoGen, Eli Lilly has come back to the table with a new, wide-ranging deal worth up to $1.7 Lilly is thought to be the first pharma company to sign up to use the new camptothecin payload platform. million payment to the biotech.

Antibody 52

Antibody Licensing Licensing Drugs 52

Camargo

MARCH 9, 2021

FDA: Sponsors Seldom Disclose RTF Letters’ Existence or Contents and Often Ignore Agency Advice. The FDA revealed that pharma companies are not forthcoming when they publicly disclose the reasons behind a refuse-to-file (RTF) letter from the Agency.

Development 146

Development Manufacturing Drugs Production 146

pharmaphorum

MARCH 2, 2022

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 104

Life Science Clinical Trials Clinical Trials Trials 104

Delveinsight

SEPTEMBER 16, 2021

FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug. Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodium phenylbutyrate (PB) and Taurursodiol (TURSO)), for the treatment of Amyotrophic lateral sclerosis (ALS).

Drugs 72

Drugs Trials Marketing FDA Approval 72

XTalks

MAY 25, 2021

AbbVie (NYSE:ABBV) continues to face heat over complaints of patent exploitation and price hikes of its world’s best-selling drug Humira (adalimumab) to build a market monopoly and block out Humira biosimilar competition. A recent congressional probe provided confirmation of the claims. Biosimilars. Humira Biosimilars: Alvotech Lawsuit.

Production 98

Production Drugs Marketing Sales 98

Delveinsight

MARCH 1, 2021

Unfavorable drug uptake would automatically yield a lesser return on the investment done by the pharma players, thus, these diseases were abandoned or say orphaned. So far, the USFDA has approved drugs and biologics for over 800 rare disease indications. While more than 150 orphan drugs have been approved in the EU.

Marketing 52

Marketing Clinical Trials Clinical Trials Drugs 52

Delveinsight

AUGUST 2, 2020

The company has also signed a licensing agreement with Ono Pharmaceutical , a Japanese pharma company, transferring exclusive rights to develop and commercialise anamorelin in Japan, South Korea, and Taiwan. Cancer Cachexia Pipeline. Apart from the products as mentioned earlier, Tetra Bio?Pharma,

Marketing 94

Marketing Pharma Companies Development Hormones 94

pharmaphorum

AUGUST 10, 2021

Private equity group Carlyle has said it won’t raise its offer for respiratory drug specialist Vectura to match a 165p per share offer from tobacco giant Philip Morris International (PMI). OtiTopic has said it intends to complete late-stage trials and file for FDA approval of the drug next year.

Regulation 52

Regulation FDA Approval Pharma Companies Marketing 52

pharmaphorum

APRIL 26, 2022

At the same time, the pharma industry has also started to note the potential for a new treatment paradigm to be developed, and investment into the space has started to increase. The treatment has been granted US FDA breakthrough therapy designation and orphan drug designation, and has also completed a phase 3 clinical study.

Containment 113

Containment Development Production Immune Response 113

pharmaphorum

DECEMBER 23, 2020

The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. The FDA has gone on to grant a fast review of the results ahead of a regulatory decision on the new lung cancer indication next year.

Marketing 80

Marketing Gene Silencing Gene Drugs 80

pharmaphorum

SEPTEMBER 8, 2022

It is a similar approach to that of another form of oncology treatment that is also experiencing a surge of interest, antibody-drug conjugates (ADCs). Last year, the company signed two deals in quick succession, which saw it form a licensing deal worth $1.3 The drug was added to Novartis’ portfolio through a $2.1

Manufacturing 104

Manufacturing Development Drugs Antibody 104

pharmaphorum

OCTOBER 5, 2020

The 68-year-old – credited with being a catalyst for Merck’s highly lucrative move into cancer immunotherapy – will officially retire from the big pharma company at the end of the year. He will be succeeded by Dean Li, who is currently Merck’s senior vice president of discovery sciences and translational medicine.

Sales 52

Sales Medicine FDA Approval Vaccination 52

pharmaphorum

OCTOBER 29, 2020

Gilead Sciences is the first and so far only company to claim FDA approval for a COVID-19 treatment with its Veklury antiviral, and its latest financial results reveal the benefit of that achievement. The bulk of the Veklury sales ($785 million) were in the US, with Europe accounting for a sizeable chunk of the remainder.

Sales 53

Sales FDA Approval Pharma Companies Vaccination 53

pharmaphorum

AUGUST 4, 2021

This SMA Awareness month , we look at how digital health solutions can complement and enhance the effectiveness of drug-based treatments for rare diseases and make a positive difference in the life of patients. This changed with the 2017 release of Biogen’s Spinraza, the first FDA-approved therapy for SMA. About the author.

Gene Therapy 145

Gene Therapy FDA Approval Pharma Companies Development 145

Find Me Cure

SEPTEMBER 2, 2020

Low levels of trust in Pharma companies combined with a lack of sufficient understanding of the clinical trial process, broken communication between all parties involved, and the complicated language of medical research are the ingredients to a lot of skepticism on the part of patients. . Does the drug work?

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97